Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 420

1.

[Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].

Wolthers OD, Høst A, Frederiksen B, Halken S.

Ugeskr Laeger. 2012 Aug 27;174(35):1989-92. Danish.

PMID:
22929576
2.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.

J Allergy Clin Immunol. 2006 Apr;117(4):802-9.

PMID:
16630937
3.

Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.

Senna GE, Calderon M, Milani M.

Expert Rev Clin Immunol. 2011 Jan;7(1):21-7. doi: 10.1586/eci.10.89.

PMID:
21162646
4.

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.

Didier A, Malling HJ, Worm M, Horak F, Sussman G, Melac M, Soulié S, Zeldin RK.

Clin Exp Allergy. 2013 May;43(5):568-77. doi: 10.1111/cea.12100.

PMID:
23600548
5.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
6.

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.

J Allergy Clin Immunol. 2011 Sep;128(3):559-66. doi: 10.1016/j.jaci.2011.06.022. Epub 2011 Jul 29.

PMID:
21802126
7.

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.

Nelson H, Lehmann L, Blaiss MS.

Curr Med Res Opin. 2012 Jun;28(6):1043-51. doi: 10.1185/03007995.2012.684676. Epub 2012 May 9. Review.

PMID:
22502864
8.

Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study.

de Blay F, Barnig C, Kanny G, Purohit A, Leynadier F, Tunon de Lara JM, Chabane H, Guérin L; SUBLIM Group.

Ann Allergy Asthma Immunol. 2007 Nov;99(5):453-61.

PMID:
18051216
9.

Effect of AIT in children including potential to prevent the development of asthma.

Valovirta E.

Allergy. 2011 Jul;66 Suppl 95:53-4. doi: 10.1111/j.1398-9995.2011.02640.x.

PMID:
21668856
10.

Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial.

Wessel F, Chartier A, Meunier JP, Magnan A.

Clin Drug Investig. 2012 Jul 1;32(7):451-63. doi: 10.2165/11634270-000000000-00000.

PMID:
22594491
11.

Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.

Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.

Allergy. 2006 Oct;61(10):1177-83.

PMID:
16942565
12.

Oralair(®): a causal treatment for grass pollen-induced allergic rhinoconjunctivitis.

Köberlein J, Mösges R.

Immunotherapy. 2013 Jan;5(1):13-21. doi: 10.2217/imt.12.147. Review.

PMID:
23256794
13.

Rush immunotherapy with sublingual administration of grass allergen extract.

Feliziani V, Marfisi RM, Parmiani S.

Allergol Immunopathol (Madr). 1993 Sep-Oct;21(5):173-8.

PMID:
8160561
14.

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.

Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK.

J Allergy Clin Immunol. 2012 Dec;130(6):1327-34.e1. doi: 10.1016/j.jaci.2012.08.032. Epub 2012 Oct 31.

PMID:
23122534
15.

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis.

Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, André C.

Allergy. 1999 Aug;54(8):819-28.

16.
17.

The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis.

Röder E, Berger MY, Hop WC, de Groot H, van Wijk RG.

Pediatr Allergy Immunol. 2013 Feb;24(1):39-48. doi: 10.1111/j.1399-3038.2012.01329.x. Epub 2012 Aug 13.

PMID:
22882319
18.
19.
20.

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M.

J Allergy Clin Immunol. 2007 Dec;120(6):1338-45. Epub 2007 Nov 1.

PMID:
17935764

Supplemental Content

Support Center